Menu ×

CHEMICALS AND ADVANCED MATERIALS

Nervous System Active Pharmaceutical Ingredients Market Analysis by Product (Cytokines, Vaccines, Fusion Proteins, Blood Factors, Therapeutic Enzymes, and Others); by Expression System (Mammalian, Microbial, Yeast, and Others); and by Application (Diabetes, CVDs, Oncology, and Neurological Disorders) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More

IN THE NEWS

  • June 12, 2022 - Boehringer Ingelheim International GmbH to become a partner of CarthroniX, a biopharmaceutical company, to develop therapies based on small molecules to cure diseases associated with elderly people. The research and development are further associated with small molecule therapeutics in canine oncology.

  •  August 16, 2022 - F. Hoffmann-La Roche Ltd to acquire acceptance from FDA for its Biologics License Application. The application is associated with untreated diffuse large B-cell lymphoma.  

Global Nervous System Active Pharmaceutical Ingredients Market Size, Forecast, and Trend Highlights Over 2022 - 2031

Nervous System Active Pharmaceutical Ingredients Market Forecast Chart

The global nervous system active pharmaceutical ingredients market is estimated to garner robust revenue by the end of 2031 by growing at a CAGR of ~5% over the forecast period, i.e., 2022 – 2031. Further, the market generated substantial revenue in the year 2021. The higher prevalence of Alzheimer’s among geriatrics is expected to be one of the major growth factors of the market throughout the forecast period. For instance, 1 out of every 9 individuals is diagnosed with Alzheimer’s globally.

Nervous System Active Pharmaceutical Ingredients Market Overview Chart

Nervous system active pharmaceutical ingredients are particular substances found in the drugs that are administered by consumers for beneficial health effects. Nervous system active pharmaceutical ingredients are generally consumed to treat certain medical conditions by imposing an effect on the spinal cord and brain. The global nervous system active pharmaceutical ingredients market is further expected to flourish on the back of higher utilization of these ingredients to treat chronic and acute pain during the forecast period. For instance, about 20% of adults admitted to be suffering from chronic pain in 2019.

Global Nervous System Active Pharmaceutical Ingredients Market: Growth Drivers and Challenges

Growth Drivers

  • Escalating Cases of Cancer- As of 2020, cancer accounted to more than 8 million deaths across the globe, out of which, 2.26 million cases of breast cancer and 2.21 million cases of lung cancer were diagnosed in a similar year. Cancer is one of the major chronic diseases that causes the highest number of death. A person with cancer has to undergo particular therapies and deal with severe pain. In these conditions, active pharmaceutical ingredients are taken to relieve pain. Hence, such a requirement is anticipated to propel the growth of the market during the forecast period.

  • Growing Geriatrics Population GloballyBased on the report provided by the World Bank, in 2021, the number of people aged 65 and over was stated to be 747,2338,580.

  • Higher Prevalence of Diabetes- As of 2019, approximately 35 million Americans were noticed to be living with diabetes summing up to about 10% of the population.

  • Significant Growth in the Healthcare Expenditure- A report published by the World Bank showed the global healthcare expenditure reached 1,121.9 per capita.

Challenges

  • Possibility of Side-Effects
  • Shortage of the Required Ingredients 
  • Lack of Awareness of Medication

The global nervous system active pharmaceutical ingredients market is segmented and analyzed for demand and supply by application into diabetes, CVDs, oncology, and neurological disorders, out of which, CVDs segment is projected to acquire the largest market share over the forecast period. The segment is estimated to grow on the back of rising cases of chronic diseases across the globe. For Instance, approximately 40 million people die due to chronic diseases every year

Major Macro-Economic Indicators Impacting the Market Growth

Nervous System Active Pharmaceutical Ingredients Market Regional Growth By Year Chart

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Nervous System Active Pharmaceutical Ingredients Market Regional Synopsis

Regionally, the global nervous system active pharmaceutical ingredients market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in the North America region is projected to hold the largest market share by the end of 2031. The growth of the market in the region is accounted to the escalating number of geriatrics with severe chronic diseases. Data provided by the World Bank showed that in 2021, the number of people aged 65 or above was 56,545,938. Furthermore, the higher prevalence of neurological disorders and rising healthcare expenditure in the region are also expected to hike the growth of the market during the forecast period.

Nervous System Active Pharmaceutical Ingredients Market Share Chart

The global nervous system active pharmaceutical ingredients market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global nervous system active pharmaceutical ingredients market includes the following segments:

By Product

  • Cytokines
  • Vaccines
  • Fusion Proteins
  • Blood Factors
  • Therapeutic Enzymes
  • Others

By Expression System

  • Mammalian
  • Microbial
  • Yeast
  • Others

By Application

  • Diabetes
  • CVDs
  • Oncology
  • Neurological Disorders

 

Top Featured Companies Dominating the Global Nervous System Active Pharmaceutical Ingredients Market

  • Pfizer, Inc.

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Company
  • Shenzhen Hepalink Pharmaceutical Co. Ltd. 
  • GSK plc
  • F. Hoffmann-La Roche Ltd
  • Cipla Inc.
  • Eli Lilly and Company
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved